Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients.

Abstract

Baseline TTD and smear grading predicted month 2 culture conversion, relapse and also recurrence. These markers may be useful to identify non-HIV-infected patients at risk of recurrence, and may be relevant in clinical trials.